WKRC: Local researchers working on a new potential way to treat eye diseases
UC led research may soon have a new kinder, gentler way to treat eye diseases.
UC drug delivery researcher Kevin Li, a professor in the James L. Winkle College of Pharmacy, takes the lead on new research looking for different ways to treat eye diseases such as macular degeneration and diabetic retinopathy. Currently, these diseases are treated with direct eye injections.
In an interview with WKRC, co-researcher Michael Yang, a pediatric ophthalmologist at Cincinnati Children’s Hospital Medical Center, explains how this federally funded study will seek alternatives to current drug delivery methods.
The study is a collaboration between UC, CCHMC and Ohio State University.
Featured image at top of eye. Photo/Victor Freitas/unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Atlanta Journal Constitution: Ointment kills...
December 3, 2021
The Atlanta Journal Constitution published a story on research at the University of Cincinnati College of Medicine possibly adding a weapon to hospitals’ bacteria fighting arsenal.Using the topical drug called AB569 — a combination of acidified nitrite and ethylenediaminetetraacetic acid — promotes killing of antibiotic-resistant bacteria while enhancing the healing of wounds in a variety of burn injuries, the study found. The study was published in the journal Infection and Immunity.
WCPO: UC study: Your kid's screen time might not be as...
December 2, 2021
WCPO covers UC study on children and media use during the pandemic summer of 2020
Keisha Love named Vice Provost for Faculty Advancement and...
December 2, 2021
Keisha Love Named Vice Provost for Faculty Advancement and Academic Inclusion